Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page
- Check5 days agoChange DetectedVersion upgraded from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check19 days agoChange DetectedThe webpage has been updated to include specific facility names and locations in Brazil, while also removing previous location terms and abbreviations. Additionally, new topics related to drug safety and post-COVID conditions have been introduced.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.